- CME Offerings
- Featured Programs
- Symposia
- Webcasts
- eSupplements
- Audiocasts
- Live Dinner Meetings
Content available soon!
Archived Symposia Broadcasts
Great Debates in Functional GI Disorders: Discussing the Clinical Implications of Fecal Incontinence and IBS
Brooks Cash, MD; Lin Chang, MD; Philip Schoemfeld, MD; William D.Chey, MD. Mark Pimental, MD
Recorded CME Event
Gi News Tonight: Clinical Updates in IBS
Nicholas Talley, MD; William Chey, MD; Lin Chang, MD; Mark Pimentel, MD; Philip Schoenfeld, MD
Recorded CME Event
Trial by Jury: Examining the ACG Position Statement on the Management of IBS
Stephen B. Hanauer, MD; Maria T. Abreu, MD; Edward Loftus, MD; Scott Plevy, MD
Recorded CME Event
Prime Time Live: The Clinical Implications of IBS
Nicholas Talley, MD; William Chey, MD; Lin Chang, MD; Mark Pimentel, MD; Philip Schoenfeld, MD
Recorded CME Event
IBS 2020 Expert Perspectives on New Guidelines
David Kunkel, MD
Mark Pimentel, MD
Didactic Lecture
IBS PRIME 2020
Brooks Cash, MD
Didactic Lecture
IBS PRIME 2020
Ronnie Fass, MD
Didactic Lecture
Causes of esophageal dysmotility
Rick Davis, PA-C
Didactic Lecture
Management of esophageal dysmotility
Gwen Cassidy, MSN, MFA, RN, APN, AGACNP-BC
Didactic Lecture
Celiac Disease
Sandra Bernklau, RN, MSN, APRN-BC, CGRN
Didactic Lecture
GHAPP Conference: Optimizing the Management of SIBO/SIFO
Nicole Martinez de Andino, RD, APRN
Didactic Lecture
GHAPP Conference: Current Perspectives on Food Intolerances
Kate Scarlata, RDN, LDN
Didactic Lecture
GHAPP Conference: IBS Applying New Advances into Practic
Richard Davis, PA-C ; Amy Kassebaum, PA-C, RD, MMS
Didactic Lecture
Xpert Perspectives on IBS from DDW 2018 in Washington, DC
Mark Pimentel, MD; William D. Chey, MD;
Didactic Lecture
The Role of the Microbiome in Health and Disease
Mark Pimentel, MD; Janelle C. Arthur, PhD; Mark S. Riddle, MD, DrPH; Gary D. Wu, MD
Didactic Lecture
Holistic Approach to Diagnosis and Management of Irritable Bowel Syndrome
Amy Kassebaum, PA-C
Didactic Lecture
Opioid Induced and Exacerbated Constipation Importance, Definitions and Rationale for a Change in Nomenclature
Amy Kassebaum, PA-C
Didactic Lecture
Small Intestinal Bacterial (SIBO) and Fungal Overgrowth (SIFO)
Nicole Martinez de Andino, RD, APRN
Didactic Lecture
Behavioral Medicine for Digestive Health
Sarah Quinton, PsyD
Didactic Lecture
Trial By Jury
Brooks Cash, MD; William D. Chey, MD; Anthony Lembo, MD; Baha Moshiree, MD; Mark Pimentel, MD
Didactic Lecture
IBS Prime
Brooks Cash, MD; Philip Schoenfeld, MD;
Didactic Lecture
Xpert Perspectives on IBS from ACG/WCOG in Orlando
William D. Chey, MD; Brian E. Lacy, MD; Mark Pimentel, MD
Didactic Lecture
Xpert Perspectives on OIC from DDW 2017 in Chicago, IL
William D. Chey, MD
Didactic Lecture
Negative Effects of Opioids on the Gastrointestinal Tract and The Development of Newer Therapeutics To Overcome Them
Darren M. Brenner, MD
Didactic Lecture
Optimizing Management of IBS-C and CIC
Nicholas J. Talley, MD (chair), Darren M. Brenner, MD, William D. Chey, MD, Philip S. Schoenfeld, MD
Didactic Lecture
Improving Patient Outcomes in IBS-D: New Evidence on Epidemiology, Pharmacology, and Mgmt
Lin Chang, MD (chair), William D. Chey, MD, FACG, AGAF, FACP, RFF, Mark Pimentel, MD, FRCP(C), Philip S. Schoenfeld, MD, MSEd, MSc (Epi)
Didactic Lecture
Beyond Gut Instincts: Applying the latest IBS advances to practice
William D. Chey, MD, Stanley A Cohen, MD, Nicholas Talley, MD, Mark Pimentel, MD, Philip S. Schoenfeld, MD
Didactic Lecture
Functional dyspepsia: A new disease model
Nick Talley, MD
Didactic Lecture
Integrating Novel Diagnostic Strategies into Practice: Key Points
Stanley Cohen, MD
Didactic Lecture
Novel Strategies for IBS-C
Mark Pimentel, MD
Didactic Lecture
Management of Severe Constipation: Dysnnergic Defecation and OIC
Philip Schoenfeld, MD
Didactic Lecture
Which Diet is Right for IBS?
William Chey, MD
Didactic Lecture
Emerging Medical Management Options for IBS-D
William Chey, MD
Didactic Lecture
Overview of IBS-C Therapies
Christine Frissora, MD
Didactic Lecture
A Primer on the Diagnosis and Management of Functional Dyspepsia
Brian Lacy, MD
Didactic Lecture
Distinguishing Celiac Disease, Non-Gluten Sensitivity and IBS
Lucinda Harris, MD
Didactic Lecture
Understanding and Managing Gastroparesis
Linda Nguyen, MD
Didactic Lecture
Opioid-Induced Bowel Dysfunction
Darren Brenner, MD
Didactic Lecture
Xpert Perspectives: New Insights into the Recognition and Management of FGIMDs 2015
Brooks Cash, MD, William Chey, MD, Mark Pimentel, MD
Didactic Lecture
Gi News Tonight: Case Discussions on Functional GI and Motility Disorders
Lawrence Schiller, MD, Lin Chang, MD, Mark Pimentel, MD, Philip Schoenfeld, MD
Didactic Lecture
Up-To-Date Diagnosis and Management of IBS and chronic Constipation in Primary Care
1.0 AMA PRA Category 1 Credit(s)™
Understanding and Managing IBS and CIC in the primary care setting
1.0 AMA PRA Category 1 Credit(s)™
An Evidence-Based Approach to IBS and CIC: Applying New Advances to Daily Practice
1.0 AMA PRA Category 1 Credit(s)™
Advances in IBS
1.0 AMA PRA Category 1 Credit(s)™
IBS News Tonight
1.0 AMA PRA Category 1 Credit(s)™
Gastroparesis: Diagnosis and Management
1.0 AMA PRA Category 1 Credit(s)™
Managing the Gastrointestinal Effects of Opioids
1.0 AMA PRA Category 1 Credit(s)™
Implementing Effective Patient Communication Skills in IBS
1.0 AMA PRA Category 1 Credit(s)™
Advances in the Management of FGIDs
The management of functional gastrointestinal disorders (FGIDs)—which encompass a broad range of conditions that are characterized by persistent, recurrent symptoms in the absence of clear structural abnormalities1 has undergone a major shift in the past decade, from poorly recognized, often misunderstood symptom complexes to conditions with clear diagnoses and better delineated treatment pathways. Nowhere is this better illustrated than in the increasing pace of original research publications and abstracts at major international meetings focusing on FGIDs. This monograph serves as a summary of highlights from 2013 meetings and literature focusing on these common and clinically consequential disorders.
Gut Microbes: Role in Health and GI Related Disorders
In this supplement, the importance of gut microflora in human health and disease is examined. Emphasis is placed on novel topics with recent discoveries that will guide the future of this area. Yet, it is important to remember that we have a symbiotic relationship with our gut colonists. For Charles Darwin once stated, "In the long history of humankind (and animal kind, too) those who learned to collaborate and improvise most effectively have prevailed." Please click on the selection to view the entire supplement.
- GI News & Library
- Reuters News
- Journal Abstracts
- Slide Library
- Congress Calendar
- Written expressive disclosure in adults with irritable bowel syndrome: A randomized controlled trial
- Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial
- Leveraging Human Microbiome Features to Diagnose and Stratify Children with Irritable Bowel Syndrome
- Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link?
- The "Biology-First" Hypothesis: Functional disorders may begin and end with biology-A scoping review
- Trial By Jury: Irritable Bowel Syndrome
- Optimizing Management of IBS-C and CIC: How Far Have We Come and Where Are We Going?
- Improving Patient Outcomes in IBS-D: New Evidence on Epidemiology, Pharmacology, and Management
- An Evidence-based Approach to IBS and CIC: Applying New Advances to Daily Practice
- Functional dyspepsia: A new disease model
- Integrating Novel Diagnostic Strategies into Practice: Key Points
- Novel Strategies for IBS-C
- Beyond Gut Instincts: Applying the Latest IBS Advances to Practice
Content available soon!
© Copyright 2013-2021 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only.
Use of this website is governed by the GIHF terms of use and privacy statement.
